These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

137 related items for PubMed ID: 11728835

  • 1. Fluphenazine plasma level monitoring for patients receiving fluphenazine decanoate.
    Marder SR, Aravagiri M, Wirshing WC, Wirshing DA, Lebell M, Mintz J.
    Schizophr Res; 2002 Jan 01; 53(1-2):25-30. PubMed ID: 11728835
    [Abstract] [Full Text] [Related]

  • 2. Plasma levels of fluphenazine in patients receiving fluphenazine decanoate. Relationship to clinical response.
    Marder SR, Midha KK, Van Putten T, Aravagiri M, Hawes EM, Hubbard JW, McKay G, Mintz J.
    Br J Psychiatry; 1991 May 01; 158():658-65. PubMed ID: 1860020
    [Abstract] [Full Text] [Related]

  • 3. Impact of clinical pharmacokinetics on neuroleptic therapy in patients with schizophrenia.
    Midha KK, Hubbard JW, Marder SR, Marshall BD, Van Putten T.
    J Psychiatry Neurosci; 1994 Jul 01; 19(4):254-64. PubMed ID: 7918346
    [Abstract] [Full Text] [Related]

  • 4. Monitoring plasma levels of fluphenazine during chronic therapy with fluphenazine decanoate.
    Miller RS, Peterson GM, McLean S, Westhead TT, Gillies P.
    J Clin Pharm Ther; 1995 Apr 01; 20(2):55-62. PubMed ID: 7650075
    [Abstract] [Full Text] [Related]

  • 5. A randomized clinical trial of haloperidol decanoate and fluphenazine decanoate in the outpatient treatment of schizophrenia.
    Chouinard G, Annable L, Campbell W.
    J Clin Psychopharmacol; 1989 Aug 01; 9(4):247-53. PubMed ID: 2570086
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Fluphenazine levels during maintenance treatment of recent-onset schizophrenia: relation to side effects, psychosocial function and depression.
    Gitlin MJ, Nuechterlein KH, Mintz J, Fogelson D, Bartzokis G, Ventura J, Subotnik K, Aravagiri M.
    Psychopharmacology (Berl); 2000 Mar 01; 148(4):350-4. PubMed ID: 10928306
    [Abstract] [Full Text] [Related]

  • 9. Fluphenazine decanoate: a clinical problem?
    Inderbitzin LB, Lewine RR, Gloersen BA, Rosen PB, McDonald SC, Vidanagama BP.
    Am J Psychiatry; 1989 Jan 01; 146(1):88-91. PubMed ID: 2563210
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Fluphenazine vs placebo supplementation for prodromal signs of relapse in schizophrenia.
    Marder SR, Wirshing WC, Van Putten T, Mintz J, McKenzie J, Johnston-Cronk K, Lebell M, Liberman RP.
    Arch Gen Psychiatry; 1994 Apr 01; 51(4):280-7. PubMed ID: 8161288
    [Abstract] [Full Text] [Related]

  • 12. Very high dose fluphenazine decanoate: a controlled trial in chronic schizophrenia.
    McClelland HA, Farquharson RG, Leyburn P, Furness JA, Schiff AA.
    Arch Gen Psychiatry; 1976 Dec 01; 33(12):1435-9. PubMed ID: 11760
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Low- and conventional-dose maintenance therapy with fluphenazine decanoate. Two-year outcome.
    Marder SR, Van Putten T, Mintz J, Lebell M, McKenzie J, May PR.
    Arch Gen Psychiatry; 1987 Jun 01; 44(6):518-21. PubMed ID: 3555385
    [Abstract] [Full Text] [Related]

  • 16. Fluphenazine decanoate in acute and maintenance therapy of schizophrenia.
    Altamura AC, Mauri MC, Guercetti G, Cazzullo CL.
    Prog Neuropsychopharmacol Biol Psychiatry; 1987 Jun 01; 11(5):613-23. PubMed ID: 3122268
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Fluphenazine enanthate and fluphenazine decanoate in the treatment of schizophrenic outpatients: extrapyramidal symptoms and therapeutic effect.
    Chouinard G, Annable L, Ross-Chouinard A.
    Am J Psychiatry; 1982 Mar 01; 139(3):312-8. PubMed ID: 6120655
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.